Explore the challenges of ADC characterization, key techniques, and the benefits of partnering with a CDMO for effective ...

喜树碱是一种主要由假柴龙树属（茶茱萸科）、喜树（蓝果树科）、蛇根草属（茜草科）等植物类群产生的用于化学防御的单萜喹啉类生物碱，其通过抑制DNA拓扑异构酶I和诱导癌细胞dsDNA断裂，在治疗肺癌、肠癌等癌症方面表现出良好的抗癌活性，是继紫杉醇和长春花生 ...

2024年9月13日-17日，欧洲肿瘤内科学会（ESMO）年会将于在西班牙巴塞罗那召开，作为肿瘤内科最高规模的国际盛会，涉及肺癌、乳腺癌、消化道肿瘤、泌尿生殖系统肿瘤等领域的多项研究届时皆将披露最新进展。

K Heran Darwin is at New York University Grossman School of Medicine and a regular columnist for EMBO reports.

In an interview with Targeted Oncology, Mark R. Litzow, MD, discussed the incorporation of Immunotherapy into upfront acute ...

Aldoxorubicin is under clinical development by LadRx and currently in Phase II for Triple-Negative Breast Cancer (TNBC).

The antibody-drug conjugate (ADC) puxitatug samrotecan (AZD8205) demonstrated a manageable safety profile consistent with ...

FAO is catalyzed by the mitochondrial trifunctional protein (MTP) and, if overloaded, generates ROS. ROS are boosted during ...

Pivekimab sunirine is a monoclonal antibody conjugated commercialized by AbbVie, with a leading Phase II program in Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia).

Venice: Maura Delpero's sophomore feature is elegantly composed but overly sedate.